MCRB analyst estimates

Seres Therapeutics (MCRB) analyst ratings, the average price target and its range, and every firm's latest call.

MCRB analyst ratings and price targets

DateFirmCallTarget
Jun 23, 2026H.C. WainwrightSeres Therapeutics initiated with a Buy at H.C. Wainwright$12.00
Jun 7, 2024Chardan CapitalSeres Therapeutics price target lowered to $1.25 from $6 at Chardan$1.25